These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 25968653)

  • 1. Dynamic changes in myeloid derived suppressor cell subsets following renal transplant: A prospective study.
    Hock BD; McKenzie JL; Cross NB; Currie MJ
    Transpl Immunol; 2015 Jun; 32(3):164-71. PubMed ID: 25968653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal transplant recipients have elevated frequencies of circulating myeloid-derived suppressor cells.
    Hock BD; Mackenzie KA; Cross NB; Taylor KG; Currie MJ; Robinson BA; Simcock JW; McKenzie JL
    Nephrol Dial Transplant; 2012 Jan; 27(1):402-10. PubMed ID: 21617199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid-Derived Suppressor Cells in Lung Transplantation.
    Heigl T; Singh A; Saez-Gimenez B; Kaes J; Van Herck A; Sacreas A; Beeckmans H; Vanstapel A; Verleden SE; Van Raemdonck DE; Verleden G; Vanaudenaerde BM; Hartl D; Vos R
    Front Immunol; 2019; 10():900. PubMed ID: 31080450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous squamous cell carcinomas with markers of increased metastatic risk are associated with elevated numbers of neutrophils and/or granulocytic myeloid derived suppressor cells.
    Seddon A; Hock B; Miller A; Frei L; Pearson J; McKenzie J; Simcock J; Currie M
    J Dermatol Sci; 2016 Aug; 83(2):124-30. PubMed ID: 27160951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-derived suppressor cells in human peripheral blood: Optimized quantification in healthy donors and patients with metastatic renal cell carcinoma.
    Flörcken A; Takvorian A; Singh A; Gerhardt A; Ostendorf BN; Dörken B; Pezzutto A; Westermann J
    Immunol Lett; 2015 Dec; 168(2):260-7. PubMed ID: 26462434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Accumulation of High Levels of Monocytic Myeloid-Derived Suppressor Cells Enhances Graft Survival in Almost-Tolerant Kidney Transplant Recipients.
    Du XX; Guo YL; Zhao YP; Yang M; Chang S; Liu B; Cai LJ; Chen ZK
    Transplant Proc; 2018 Dec; 50(10):3314-3320. PubMed ID: 30577201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent accumulation of circulating monocytic myeloid-derived suppressor cells contributes to post-infectious immunosuppression in renal transplant recipients with bacterial infection: A pilot study.
    Jiang Y; Feng S; Ji J; Lin Z; Zhang X
    Transpl Immunol; 2018 Jun; 48():10-17. PubMed ID: 29477752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A major role for myeloid-derived suppressor cells and a minor role for regulatory T cells in immunosuppression during Staphylococcus aureus infection.
    Tebartz C; Horst SA; Sparwasser T; Huehn J; Beineke A; Peters G; Medina E
    J Immunol; 2015 Feb; 194(3):1100-11. PubMed ID: 25548227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.
    Greifenberg V; Ribechini E; Rössner S; Lutz MB
    Eur J Immunol; 2009 Oct; 39(10):2865-76. PubMed ID: 19637228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma.
    Chevolet I; Speeckaert R; Schreuer M; Neyns B; Krysko O; Bachert C; Van Gele M; van Geel N; Brochez L
    J Transl Med; 2015 Jan; 13():9. PubMed ID: 25592374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increase in both CD14-positive and CD15-positive myeloid-derived suppressor cell subpopulations in the blood of patients with glioma but predominance of CD15-positive myeloid-derived suppressor cells in glioma tissue.
    Gielen PR; Schulte BM; Kers-Rebel ED; Verrijp K; Petersen-Baltussen HM; ter Laan M; Wesseling P; Adema GJ
    J Neuropathol Exp Neurol; 2015 May; 74(5):390-400. PubMed ID: 25853692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloid-Derived Suppressor Cells in Kidney Transplant Recipients and the Effect of Maintenance Immunotherapy.
    Iglesias-Escudero M; Sansegundo-Arribas D; Riquelme P; Merino-Fernández D; Guiral-Foz S; Pérez C; Valero R; Ruiz JC; Rodrigo E; Lamadrid-Perojo P; Hutchinson JA; Ochando J; López-Hoyos M
    Front Immunol; 2020; 11():643. PubMed ID: 32425928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary assessment of the feasibility of autologous myeloid-derived suppressor cell infusion in non-human primate kidney transplantation.
    Ezzelarab MB; Perez-Gutierrez A; Humar A; Wijkstrom M; Zahorchak AF; Lu-Casto L; Wang YC; Wiseman RW; Minervini M; Thomson AW
    Transpl Immunol; 2019 Oct; 56():101225. PubMed ID: 31330261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granulocytic myeloid-derived suppressor cells are cryosensitive and their frequency does not correlate with serum concentrations of colony-stimulating factors in head and neck cancer.
    Trellakis S; Bruderek K; Hütte J; Elian M; Hoffmann TK; Lang S; Brandau S
    Innate Immun; 2013 Jun; 19(3):328-36. PubMed ID: 23160385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monocytic myeloid-derived suppressor cells accumulate in renal transplant patients and mediate CD4(+) Foxp3(+) Treg expansion.
    Luan Y; Mosheir E; Menon MC; Wilson D; Woytovich C; Ochando J; Murphy B
    Am J Transplant; 2013 Dec; 13(12):3123-31. PubMed ID: 24103111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Myeloid-Derived Suppressor Cell Subsets Recover Rapidly after Allogeneic Hematopoietic Stem/Progenitor Cell Transplantation.
    Guan Q; Blankstein AR; Anjos K; Synova O; Tulloch M; Giftakis A; Yang B; Lambert P; Peng Z; Cuvelier GD; Wall DA
    Biol Blood Marrow Transplant; 2015 Jul; 21(7):1205-14. PubMed ID: 25963921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft monocytic myeloid-derived suppressor cell content predicts the risk of acute graft-versus-host disease after allogeneic transplantation of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells.
    Vendramin A; Gimondi S; Bermema A; Longoni P; Rizzitano S; Corradini P; Carniti C
    Biol Blood Marrow Transplant; 2014 Dec; 20(12):2049-55. PubMed ID: 25246295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5.
    Dilek N; Poirier N; Usal C; Martinet B; Blancho G; Vanhove B
    J Immunol; 2012 May; 188(9):4209-16. PubMed ID: 22450806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells.
    Chou HS; Hsieh CC; Charles R; Wang L; Wagner T; Fung JJ; Qian S; Lu LL
    Transplantation; 2012 Feb; 93(3):272-82. PubMed ID: 22179405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.